A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: Comparative potencies and durations of action of nonpeptide antagonists
- 1 November 1986
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 39 (18), 1631-1638
- https://doi.org/10.1016/0024-3205(86)90159-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.Proceedings of the National Academy of Sciences, 1986
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.Proceedings of the National Academy of Sciences of the United States of America, 1986
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Drugs Increasing Gastrointestinal MotilityPharmacology, 1982
- CHOLECYSTOKININ: A HORMONE AND A NEUROTRANSMITTER Biomedical Research, 1982
- Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.Proceedings of the National Academy of Sciences, 1981
- Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas. Discovery of a competitive antagonist of the action of cholecystokinin.Journal of Biological Chemistry, 1979